PE Ratio
10.15
₹38.95 -2.00 (-4.88%)
As on September 2, 2026
-18.00%
1 Y CAGR
16
CR
Market Cap
Company profile
Saroja Pharma Industries India Ltd. operates within the pharmaceutical and healthcare industries, primarily engaged as a trader, exporter, and supplier of specialty chemicals, pharmaceutical active pharmaceutical ingredients (APIs), and pharma intermediates. The company provides products for human, veterinary, and pharmaceutical applications, serving markets in India, the Asia Pacific, Europe, and internationally. Its product portfolio includes various APIs such as Furosemide, Vildagliptin, and Oxfendazole, a range of pharmaceutical intermediates, and diverse chemicals and solvents like Thionyl Chloride, Benzoic Acid, and Aluminium Chloride. The company is also in the process of expanding its operations to include the manufacturing of API products.
Price Chart
Fundamentals - Company Valuation
PB Ratio
0.24
Dividend Yield
0.00%
Sector PE
47.63
Sector ROE
11.70%
Sector Dividend Yield
0.46%
Financials
LIVE DATA FEED
Total Revenue (YTD)
₹0.7KCAGR 5-Year
+5.96%Peers & Comparison
SUNPHARMA
Sun Pharmaceutical Industries Ltd
Market cap: ₹4,41,477.63 Cr
DIVISLAB
Divi's Laboratories Ltd
Market cap: ₹2,41,576.41 Cr
TORNTPHARM
Torrent Pharmaceuticals Ltd
Market cap: ₹1,82,576.57 Cr
Missed the last rally? Don’t miss the next
Looking for AI-researched technical positive stocks?
Our AI-powered Analytical Portal finds the strongest technical positive stocks with actionable Buy & Sell opportunities.
Corporate Actions
Still Thinking? Not sure which stocks are right for you?
We help investors understand what to buy, when to buy, and why it makes sense for them.
customersupport@jarvisinvest.com
New Customers (Enquiry): +91 7208809638
Mon - Sat | 10:00 AM - 07:00 PM (Sunday Closed)
